Over the course of the past month Ventripoint Diagnostics Ltd (OTCMKTS:VPTDF) has seen its stock make a steady upward move and clock gains of as much as 17% during the period. In light of such gains, it may be a good time for investors to start taking a closer look at the company and latest developments.
Market Action
On Friday, VPTDF stock ended lower by 1.12% to $0.2818 with 19k shares, compared to its average volume of 41k shares. The stock has moved within a range of $0.2720 – 0.2836 after opening trade at $0.2836.
Ventripoint Announces Up-Listing to OTCQB Venture Market
As it happens, Ventripoint Diagnostics was actually in the news last Friday after the company announced that it had got notification from the OTC Markets with regards to the uplisting to the OTCQB tier. The uplisting went into effect from January 7, 2021.
It goes without saying that it was a major development for the company and it is now going to be interesting to see if the Ventripoint Diagnostics stock can manage to attract more investors in the coming days. The stock started trading on the OTCQB exchange with the ticker symbol VPTDF.
However, at the same time, it is also important to keep in mind that the common shares are going to continue to be available on the Toronto Securities Venture Exchange with the ticker symbol VPT. It may be a good time to add Ventripoint Diagnostics to your watch lists.
Key Quote
Dr. George Adams, CEO, commented, “Trading on the OTCQB will enhance our visibility and make the Company accessible to a much broader range of U.S. investors and brokers. The quotation on the OTCQB will provide existing and potential investors with a transparent and easily accessible trading platform where they can find Real-Time quotes and market information.”
Traders Note
VPTDF stock is trading below the 10-Day and 50-Day Moving averages of $0.2823 and $0.3003. Moreover, the stock is trading is the neutral zone with RSI stands at 50.
 Stock Jumps 17% In a Month: But Why?){kind=link}